Publicaciones en las que colabora con María del Carmen Dios Vieitez (10)

2016

  1. Cyclosporine A lipid nanoparticles for oral administration: Pharmacodynamics and safety evaluation

    European Journal of Pharmaceutics and Biopharmaceutics, Vol. 101, pp. 112-118

  2. Cyclosporine A-loaded lipid nanoparticles in inflammatory bowel disease

    International Journal of Pharmaceutics, Vol. 503, Núm. 1-2, pp. 196-198

  3. Lipid nanoparticles enhance the absorption of cyclosporine A through the gastrointestinal barrier: In vitro and in vivo studies

    International Journal of Pharmaceutics, Vol. 500, Núm. 1-2, pp. 154-161

  4. Reformulating cyclosporine A (CsA): More than just a life cycle management strategy

    Journal of Controlled Release, Vol. 225, pp. 269-282

2013

  1. Ultra high performance liquid chromatography-tandem mass spectrometry method for cyclosporine a quantification in biological samples and lipid nanosystems

    Journal of Chromatography B: Analytical Technologies in the Biomedical and Life Sciences, Vol. 927, pp. 164-172

2012

  1. Lipid nanoparticles for cancer therapy: State of the art and future prospects

    Expert Opinion on Drug Delivery, Vol. 9, Núm. 10, pp. 1245-1261

2003

  1. Desarrollo y caracterización de nanopartículas de rifampicina para su aplicación en el tratamiento de la Tuberculosis

    VI Congreso de la Sociedad Española de Farmacia Industrial y Galénica. 3ª Jornadas de Tecnología Farmecéutica. Granada, 9-11 de febrero de 2003.: Libro de Comunicaciones (Comares), pp. 57-60